Share-Based Compensation (Tables)
|
6 Months Ended |
Jun. 30, 2025 |
Share-Based Payment Arrangement [Abstract] |
|
Schedule of Components of Share-Based Compensation Expense Recognized |
The following table reflects the components of share-based compensation expense recognized in our consolidated statements of operations (in millions): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2025 | | 2024 | | 2025 | | 2024 | Stock options | $ | 11.1 | | | $ | 8.1 | | | $ | 19.6 | | | $ | 13.8 | | RSUs | 26.0 | | | 19.2 | | | 49.4 | | | 34.7 | | STAP awards | — | | | 21.9 | | | (0.8) | | | 25.8 | | ESPP | 0.7 | | | 0.5 | | | 1.4 | | | 1.0 | | Total share-based compensation expense before tax | $ | 37.8 | | | $ | 49.7 | | | $ | 69.6 | | | $ | 75.3 | | | | | | | | | |
|
Schedule of Weighted-Average Assumptions to Measure the Fair Value of Stock Options |
The following weighted average assumptions were used in estimating the fair value of stock options granted to employees during the six months ended June 30, 2025 and 2024: | | | | | | | | | | | | | June 30, 2025 | | June 30, 2024 | Expected term of awards (in years) | 5.0 | | 6.5 | Expected volatility | 32.2 | % | | 31.6 | % | Risk-free interest rate | 4.1 | % | | 4.3 | % | Expected dividend yield | 0.0 | % | | 0.0 | % |
|
Schedule of Activity and Status of Stock Options |
A summary of the activity and status of stock options under the 2015 Plan during the six-month period ended June 30, 2025 is presented below: | | | | | | | | | | | | | | | | | | | | | | | | | Number of Options | | Weighted Average Exercise Price | | Weighted Average Remaining Contractual Term (in Years) | | Aggregate Intrinsic Value (in millions) | Outstanding as of January 1, 2025 | 5,571,545 | | | $ | 148.62 | | | | | | Granted | 353,966 | | | 307.24 | | | | | | Exercised | (270,000) | | | 128.73 | | | | | | Forfeited | — | | | — | | | | | | Outstanding as of June 30, 2025 | 5,655,511 | | | $ | 159.50 | | | 3.4 | | $ | 730.9 | | Exercisable as of June 30, 2025 | 4,339,265 | | | $ | 131.92 | | | 2.0 | | $ | 674.5 | | Unvested as of June 30, 2025 | 1,316,246 | | | $ | 250.40 | | | 7.9 | | $ | 56.4 | | | | | | | | | |
|
Schedule of Share-Based Compensation (Benefit) Expense Recognized |
Total share-based compensation expense related to stock options was recorded as follows (in millions): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2025 | | 2024 | | 2025 | | 2024 | Cost of sales | $ | — | | | $ | — | | | $ | — | | | $ | — | | Research and development | 0.1 | | | 0.1 | | | 0.2 | | | 0.2 | | Selling, general, and administrative | 11.0 | | | 8.0 | | | 19.4 | | | 13.6 | | Share-based compensation expense before taxes | 11.1 | | | 8.1 | | | 19.6 | | | 13.8 | | Related income tax benefit | (0.2) | | | (0.3) | | | (0.4) | | | (0.5) | | Share-based compensation expense, net of taxes | $ | 10.9 | | | $ | 7.8 | | | $ | 19.2 | | | $ | 13.3 | |
Total share-based compensation expense related to RSUs was recorded as follows (in millions): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2025 | | 2024 | | 2025 | | 2024 | Cost of sales | $ | 1.1 | | | $ | 1.1 | | | $ | 2.1 | | | $ | 2.0 | | Research and development | 7.6 | | | 5.8 | | | 14.3 | | | 11.4 | | Selling, general, and administrative | 17.3 | | | 12.3 | | | 33.0 | | | 21.3 | | Share-based compensation expense before taxes | 26.0 | | | 19.2 | | | 49.4 | | | 34.7 | | Related income tax benefit | (4.3) | | | (3.5) | | | (8.1) | | | (6.8) | | Share-based compensation expense, net of taxes | $ | 21.7 | | | $ | 15.7 | | | $ | 41.3 | | | $ | 27.9 | |
Share-based compensation expense (benefit) recognized in connection with STAP awards was as follows (in millions): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2025 | | 2024 | | 2025 | | 2024 | Cost of sales | $ | — | | | $ | 0.8 | | | $ | (0.1) | | | $ | 1.0 | | Research and development | — | | | 2.5 | | | (0.2) | | | 3.0 | | Selling, general, and administrative | — | | | 18.6 | | | (0.5) | | | 21.8 | | Share-based compensation expense (benefit) before taxes | — | | | 21.9 | | | (0.8) | | | 25.8 | | Related income tax (benefit) expense | — | | | (2.9) | | | 0.2 | | | (3.7) | | Share-based compensation expense (benefit), net of taxes | $ | — | | | $ | 19.0 | | | $ | (0.6) | | | $ | 22.1 | | | | | | | | | |
|
Schedule of Stock Option Exercise Data |
Stock option exercise data is summarized below (dollars in millions): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2025 | | 2024 | | 2025 | | 2024 | Number of options exercised | 138,526 | | | 398,149 | | | 270,000 | | | 725,416 | | Cash received | $ | 18.1 | | | $ | 52.1 | | | $ | 34.7 | | | $ | 94.3 | | Total intrinsic value of options exercised | $ | 23.7 | | | $ | 52.3 | | | $ | 52.8 | | | $ | 88.0 | |
|
Schedule of Restricted Stock Units Activity |
A summary of the activity with respect to, and status of, RSUs during the six-month period ended June 30, 2025 is presented below: | | | | | | | | | | | | | Number of RSUs | | Weighted Average Grant Date Fair Value | Unvested as of January 1, 2025 | 1,219,654 | | | $ | 225.40 | | Granted | 368,117 | | | 325.36 | | Vested | (145,968) | | | 213.81 | | Forfeited | (11,649) | | | 250.27 | | Unvested as of June 30, 2025 | 1,430,154 | | | $ | 252.11 | |
|